Nobuko Nishiura¹, Keigo Akuta¹, Yoichiro Morikawa¹, Hisashi Kato¹, Hirokazu Kashiwagi¹, Yuzuru Kanakura¹, Yoshiaki Tomiyama^1,2 (1.Department of Hematology and Oncology, Osaka Univ., Osaka, Japan, 2.Department of Blood and Transfusion, Osaka University Hospital, Osaka, Japan)

Naohito Fujishima^1,2, Masaru Togashi², Ryo Hasegawa³, Ken Watanabe³, Akiko Saga³, Ayumi Omokawa³, Tomoo Saga³, Shigeharu Ueki³, Naoto Takahashi², Kazutaka Kitaura⁴, Ryuji Suzuki⁵, Makoto Hirokawa³ (1.Division of Blood Transfusion, Akita University Hospital, Akita, Japan, 2.Department of Hematology, Akita University School of Medicine, Akita, Japan, 3.Department of General Internal Medicine, Akita University, Akita, Japan, 4.Repertoire Genesis Incorporation, Ibaraki, Japan, 5.Clinical Research Center, Sagamihara National Hospital, Sagamihara, Japan)

Fumisato Takagi, Yotaro Motomura, Tomoyuki Arimatsu, Saeko Sonokawa, Sayaka Suzuki, Keigo Okada, Takashi Kumagai (Department of Hematology, Ome Municipal General Hospital, Tokyo, Japan)

Midori Ishiyama, Masayuki Shiseki, Yuki Iizuka, Aya Watanabe, Norina Tanaka, Akihito Shinohara, Hiroshi Kazama, Shotaro Hagiwara, Kentaro Yoshinaga, Naoki Mori, Junji Tanaka (Dept Hematol., Tokyo Women's Medical University, Tokyo, Japan)

Shugo Kowata¹, Kazunori Murai², Shigeki Ito³, Tatsuo Oyake¹, Yasuhiko Tsukushi¹, Wataru Izumita¹, Ryousei Sasaki¹, Norifumi Sugawara¹, Maki Nishiya¹, Tadashi Shimoyama¹, Akihiro Otsu¹, Yoji Ishida¹, Takashi Ishida¹ (1.Hematology and Oncology, Iwate Medical University, Iwate, Japan, 2.Department of Hematology, Iwate prefecture central hospital, Iwate, Japan, 3.Department of Oncology, Iwate Medical University, Iwate, Japan)

Kaichi Nishiwaki^1,2, Mitsuji Katori^1,2, Hideki Uryu^1,2, Kei Hirano^1,2, Rika Hosoba^1,2, Tadahiro Gunji^1,2, Kazuhito Suzuki^1,2, Hidekazu Masuoka^1,2, Shingo Yano² (1.Division of Oncology and Hematology, Jikei University Kashiwa Hospital, Japan, 2.Division of Oncology and Hematology, Jikei University, Tokyo, Japan)